1234844-98-4

Upstream product

• 100-39-0 benzyl bromide 
• 1224103-63-2 ethyl (2E)-3-(3,5-difluoro-4-hydroxyphenyl)prop-2-enoate 
• 1224103-66-5 (2-(4-(benzyloxy)-3,5-difluorophenyl)-cyclopropyl)methanol 
• 1224103-65-4 2-(4-benzyloxy-3,5-difluorophenyl)cyclopropanecarboxylic acid ethyl ester 
• 1224103-64-3 2-(3,5-difluoro-4-hydroxyphenyl)cyclopropanecarboxylic acid ethyl ester 
• 104197-13-9 4-bromo-2,6-difluorophenol 
• 1224103-67-6 C₁₇H₁₄F₂O₂ 
• 4009-98-7 (methoxymethyl)triphenylphosphonium chloride 
• 4009-98-7 (methoxymethyl)triphenylphosphonium chloride 

Downstream Products

• 1224103-87-0 C₁₈H₁₆F₂O₂ 
• 1224103-88-1 C₁₈H₁₆F₂O₃ 
• 1224103-89-2 ethyl 2-(2-(4-(benzyloxy)-3,5-difluorophenyl)cyclopropyl)acetate 
• 1224103-68-7 ethyl 2-(2-(3,5-difluoro-4-hydroxyphenyl)cyclopropyl)acetate 

Relevant academic research and scientific papers

GPR120 RECEPTOR AGONISTS AND USES THEREOF

GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.

GPR120 RECEPTOR AGONISTS AND USES THEREOF

GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.

ARYL GPR120 RECEPTOR AGONISTS AND USES THEREOF

Aryl GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.